Rare diseases
Investigational molecules
Locations
Back to Italy125 clinical trials in Foggia, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
ItalyStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
ItalyStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
ItalyStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
ItalyStudy on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection Not Responding to Bulevirtide Treatment
ItalyStudy Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer
ItalyStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
ItalyStudy on Valproic Acid with Bevacizumab and Oxaliplatin/Fluoropyrimidine for Patients with RAS-Mutated Metastatic Colorectal Cancer
ItalyStudy of inotuzumab ozogamicin and drug combination in adult patients with B-cell Acute Lymphoblastic Leukemia who have minimal residual disease before stem cell transplantation
ItalyStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
ItalyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
ItalyStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic cancers and advanced treatment approaches. Studies include investigations of novel therapies for prostate cancer, colorectal cancer, and various forms of leukemia.
Research emphasizes targeted therapies and combination treatments to improve patient outcomes.
Comprehensive studies exploring treatments for multiple sclerosis and neurodegenerative conditions. Research includes evaluation of new therapeutic agents and disease-modifying treatments.
Focus on improving cognitive function and disease progression management.
Advanced research into heart failure prevention and cardiovascular disease management. Studies evaluate new therapeutic combinations and preventive strategies.
Emphasis on reducing cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
